4Bartl R, Friseh B, Burkhardt R, et al. Assessment of" bone marrow histology in the malignant lymphomas non-Hodgkin' s:eorrelation with clinical factors for diagnosis, prognosis, classification and staging[ J]. Br J Haematol, 1982,51 (4) : 511 - 530.
5Howell S, Grey M, Chang J, et al. The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centre [ J ]. Br J Haematol,2002,119 (2) :408 -411.
6Juneja SK, Wolf MM, Cooper IA. Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma[ J ]. Clin Pathol, 1990,43 (8) :630 - 632.
7Talaulikar D,Shadbolt B,Bell J,et al. Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma - a new perspective[ J ]. Histopathol- ogy,2008,52 (3) : 340 - 347.
8Schaefer NG,Strobel K,Taverna C, et al. Bone involvement in patients with lymphoma: the role of FDG-PET/CT [ J ]. Eur J Nucl Med,2007,34( 1 ) :60 -67.
9Pelosi E, Penna D, Douroukas A, et al. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy dur- ing thee staging of malignant lymphoma: results from a large muhicentre study[ J ]. Q J Nucl Med MoI Imaging,2011,55 (4) :469 -475.
